References
Cancer
CANCER
Participant flow through study protocol.F-2 Isoprostane excretion (corrected for creatinine) expressed as % of baseline. Levels were higher in the a.m. vs. p.m. and at 1–6 vs. 1 h time periods. * Main effects of time and time period, Total post-meal F2-isoprostane excretion as % of baseline. Time effect: a.m. > p.m., ** Relationship between urine post-meal F2-isoprostane and quercetin levels for each treatment and time group.Study schedule.* Baseline and 1 h post-meal, or all collected urine during 1–6 h post-meal period.Composition of the high-fat meal.Summary of MS conditions for quantified analytes.Participant characteristics (Urine F2-isoprostane concentrations by treatment, time, and time period.Model 1 analysis (includes all time periods): main effect of treatment (placebo > grape, Usual dietary intake data of participants (Data were collected, and Healthy Eating Index 2015 scores were calculated using the National Cancer Institute’s Diet History Questionnaire III assessing the past 6 months. SD = standard deviation; IQR = Interquartile Range.Antioxidant micronutrient intakes of participants during the low-antioxidant diet and usual diet.Low-antioxidant diet data were collected from food records kept by participants two days before the laboratory visit. Usual diet data were collected from a diet history questionnaire assessing the previous 6 months. SD = standard deviation; IQR = Interquartile Range; RAE = Retinol Activity Equivalent; * RDA = Recommended Dietary Allowances, US Dietary Reference Intakes. Nutrient comparisons are within rows and between the low-antioxidant days and the usual diet.